The present application describes cyclic .beta.-amino acid derivatives or
pharmaceutically acceptable salt forms thereof, wherein the central core
is a non-aromatic carbocycle or heterocycle. Compounds of the present
invention are useful as inhibitors of trypsin-like serine proteases,
specifically factor Xa.